Opus Genetics Inc (IRD) Stock Price, Quote, News & History

IRDNASDAQ
$4.18
0.122.96%
Last update: Jun 18, 10:00 AM
Loading...

Key Statistics

Open
$4.17
Close
-
Volume / Avg.
88.09K / 817.61K
Day Range
$4.14 - $4.26
52 Wk Range
0.90 - 5.81
Market Cap
$345.13M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
45
Short Interest
4.99%
Days to Cover
4.85

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-38.99M
Investing Cash Flow (TTM)
0
Financing Cash Flow (TTM)
57.15M
Free Cash Flow (TTM)
-38.99M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
18.17M

Analyst Trends and Forecast

2
Jan
5
Mar
0
0
0
0
Apr
1
May
3
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$276.46M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
25.57
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-32.27%
Earnings Yield % (FWD)
-28.20%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.56

Company Debt

Total Debt
$1.20M
LT Debt
$1.20M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$59.96M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$4.17
Close
-
Volume / Avg.
88.09K / 817.61K
Day Range
$4.14 - $4.26
52 Wk Range
0.90 - 5.81
Market Cap
$345.13M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
45
Short Interest
4.99%
Days to Cover
4.85

About

Sector
Health Care
Industry
Biotechnology
Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline include...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Opus Genetics (IRD) stock?

A

You can purchase shares of Opus Genetics (NASDAQ:IRD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Opus Genetics (IRD) competitors?

A

There are no as such competitors for Opus Genetics.

Q

What is the forecast, or price target, for Opus Genetics (IRD) stock?

A

Opus Genetics has a consensus price target of $9.86.

Q

What is the current price for Opus Genetics (IRD)?

A

The stock price for Opus Genetics (NASDAQ: IRD) is $4.18 last updated June 18, 2026 at 10:00 AM EDT.

Q

Does Opus Genetics (IRD) pay a dividend?

A

There are no upcoming dividends for Opus Genetics.

Q

When is Opus Genetics (NASDAQ:IRD) reporting earnings?

A

Opus Genetics does not have any upcoming earnings scheduled.

Q

Is Opus Genetics (IRD) going to split?

A

There is no upcoming split for Opus Genetics.

Q

What sector and industry does Opus Genetics (IRD) operate in?

A

Opus Genetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.